Persones / Equip Humà

Antoni Serrano Blanco

Buscador de publicacions

Publicacions

  • Luciano JV, Francesco D'Amico, Feliu A, McCracken LM, Aguado J, Peñarrubia-María MT, Martin Knapp, Serrano-Blanco A and García-Campayo J.

    Cost-Utility of Group Acceptance and Commitment Therapy for Fibromyalgia Versus Recommended Drugs: An Economic Analysis Alongside a 6-Month Randomized Controlled Trial Conducted in Spain (EFFIGACT Study).

    JOURNAL OF PAIN . 18(7): 868-880. Nº de cites: 31

    [doi:10.1016/j.jpain.2017.03.001]

  • Serrano-Blanco A, Rubio-Valera M, Aznar I, Baladon L, Gibert K, Gracia Canales A, Kaskens L, Ortiz JM and Salvador-Carulla L.

    In-patient costs of agitation and containment in a mental health catchment area.

    BMC Psychiatry . 17(1): 212-212. Nº de cites: 23

    [doi:10.1186/s12888-017-1373-4]

  • Aznar I, Fernández A, Gil MM, Fajó-Pascual M, Moreno-Peral P, Peñarrubia-Teresa MT, Serrano-Blanco A, Sánchez-Niubó A, March-Pujol MA, Jové AM and Rubio-Valera M.

    Initial medication non-adherence: prevalence and predictive factors in a cohort of 1.6 million primary care patients.

    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY . 83(6): 1328-1340. Nº de cites: 33

    [doi:10.1111/bcp.13215]

  • Mugica F, Nebot À, Bagherpour S, Baladon L and Serrano-Blanco A.

    A model for continuous monitoring of patients with major depression in short and long term periods.

    TECHNOLOGY AND HEALTH CARE . 25(3): 487-511. Nº de cites: 3

    [doi:10.3233/THC-161289]

  • Luciano JV, Carlos Garcia Forero, Marta Cerdà Lafont, Peñarrubia-María MT, Fernández-Vergel R, JOSE MIGUEL RUIZ MARTIN, Rozadilla A, Sirvent Alierta, Elena, Santo Panero, Pilar, García Campayo, Javier, Serrano-Blanco A and Rubio-Valera M.

    Functional Status, Quality of Life, and Costs Associated With Fibromyalgia Subgroups: A Latent Profile Analysis.

    CLINICAL JOURNAL OF PAIN . 32(10): 829-840. Nº de cites: 33

    [doi:10.1097/AJP.0000000000000336]

  • Rubio-Valera M, Huerta-Ramos ME, Baladon L, Aznar-Lou I, Ortiz JM, Luciano JV, Roset-Arisso PN, Salvador-Carulla L, Villagrán JM, Mayoral F, Gracia A and Serrano-Blanco A.

    Qualitative study of the agitation states and their characterization, and the interventions used to attend them

    ACTAS ESPANOLAS DE PSIQUIATRIA . 44(5): 166-177. Nº de cites: 10

  • Burton C, Szentagotai Tatar A, McKinstry B, Matheson C, Matu S, Moldovan R, Macnab M, Farrow E, David D, Pagliari C, Serrano-Blanco A, Wolters M and Help4Mood Consortium.

    Pilot randomised controlled trial of Help4Mood, an embodied virtual agent-based system to support treatment of depression

    JOURNAL OF TELEMEDICINE AND TELECARE . 22(6): 348-355. Nº de cites: 74

    [doi:10.1177/1357633X15609793]

  • Baladon L, Rubio-Valera M, Serrano-Blanco A, Palao DJ and Fernández A.

    Gender differences in the impact of mental disorders and chronic physical conditions on health-related quality of life among non-demented primary care elderly patients

    QUALITY OF LIFE RESEARCH . 25(6, SI): 1461-1474. Nº de cites: 14

    [doi:10.1007/s11136-015-1182-5]

  • Hargarter, L, Bergman, P, Conca, A, Serrano-Blanco A, Bitter, I, Bilankis, N and Schreiner, A.

    Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia

    EXPERT OPINION ON PHARMACOTHERAPY . 17(8): 1043-1053. Nº de cites: 24

    [doi:10.1080/14656566.2016.1174692]

  • de Araújo AA, Ribeiro SB, Dos Santos AC, Lemos TM, Medeiros CA, Guerra GC, de Araújo Júnior RF, Serrano-Blanco A and Rubio-Valera M.

    Quality of Life and Hormonal, Biochemical, and Anthropometric Profile Between Olanzapine and Risperidone Users

    PSYCHIATRIC QUARTERLY . 87(2): 293-304. Nº de cites: 5

    [doi:10.1007/s11126-015-9385-z]